嗜酸性粒细胞性哮喘-话题@MedSci

#嗜酸性粒细胞性哮喘#

6篇内容 | 566人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1976795, encodeId=44ec19e6795e9, content=<a href='/topic/show?id=72854023e82' target=_blank style='color:#2F92EE;'>#嗜酸性粒细胞性哮喘#</a>, objectTitle=JAIP：美泊利单抗治疗重度嗜酸性粒细胞性哮喘后的糖皮质激素反应性, objectType=article, longId=733175, objectId=8090e33175b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8090e33175b6, replyNumber=0, likeNumber=32, createdTime=2022-07-24, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8090e33175b6, moduleTitle=JAIP：美泊利单抗治疗重度嗜酸性粒细胞性哮喘后的糖皮质激素反应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8090e33175b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976794, encodeId=02af19e6794c0, content=<a href='/topic/show?id=72854023e82' target=_blank style='color:#2F92EE;'>#嗜酸性粒细胞性哮喘#</a>, objectTitle=持续mepolizumab治疗能够让重度嗜酸性粒细胞性哮喘患者长期获益, objectType=article, longId=293807, objectId=a75c29380ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a75c29380ecf, replyNumber=0, likeNumber=29, createdTime=2022-03-15, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a75c29380ecf, moduleTitle=持续mepolizumab治疗能够让重度嗜酸性粒细胞性哮喘患者长期获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a75c29380ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976793, encodeId=543219e6793fd, content=<a href='/topic/show?id=72854023e82' target=_blank style='color:#2F92EE;'>#嗜酸性粒细胞性哮喘#</a>, objectTitle=Lancet Respirat Med：重度嗜酸性粒细胞性哮喘患者启用贝那利珠单抗后的口服激素减量情况, objectType=article, longId=218243, objectId=3c10218243d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c10218243d0, replyNumber=0, likeNumber=51, createdTime=2022-07-26, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c10218243d0, moduleTitle=Lancet Respirat Med：重度嗜酸性粒细胞性哮喘患者启用贝那利珠单抗后的口服激素减量情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c10218243d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976792, encodeId=53a119e67920e, content=<a href='/topic/show?id=72854023e82' target=_blank style='color:#2F92EE;'>#嗜酸性粒细胞性哮喘#</a>, objectTitle=Knopp Biosciences宣布开始II期临床试验评估右旋普拉克索在嗜酸性粒细胞性哮喘中的应用, objectType=article, longId=177982, objectId=e7881e798242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7881e798242, replyNumber=0, likeNumber=30, createdTime=2020-07-19, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7881e798242, moduleTitle=Knopp Biosciences宣布开始II期临床试验评估右旋普拉克索在嗜酸性粒细胞性哮喘中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7881e798242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976791, encodeId=011719e6791a9, content=<a href='/topic/show?id=72854023e82' target=_blank style='color:#2F92EE;'>#嗜酸性粒细胞性哮喘#</a>, objectTitle=CHMP推荐Nucala（mepolizumab）用于治疗重症嗜酸性粒细胞性哮喘的欧洲患儿, objectType=article, longId=145480, objectId=253814548015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=253814548015, replyNumber=0, likeNumber=36, createdTime=2018-12-04, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=253814548015, moduleTitle=CHMP推荐Nucala（mepolizumab）用于治疗重症嗜酸性粒细胞性哮喘的欧洲患儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=253814548015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976790, encodeId=379419e6790d1, content=<a href='/topic/show?id=72854023e82' target=_blank style='color:#2F92EE;'>#嗜酸性粒细胞性哮喘#</a>, objectTitle=Allergy：嗜酸性粒细胞性哮喘患者气道中嗜碱性粒细胞增加并活性！, objectType=article, longId=100123, objectId=915510012334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=915510012334, replyNumber=0, likeNumber=34, createdTime=2017-07-05, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=915510012334, moduleTitle=Allergy：嗜酸性粒细胞性哮喘患者气道中嗜碱性粒细胞增加并活性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=915510012334)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

嗜酸性粒细胞性哮喘

2020-05-29

echonoir (审核中...)

前往app查看评论内容

#嗜酸性粒细胞性哮喘#

JAIP：美泊利单抗治疗重度嗜酸性粒细胞性哮喘后的糖皮质激素反应性

2022-07-24

echonoir (审核中...)

前往app查看评论内容

#嗜酸性粒细胞性哮喘#

持续mepolizumab治疗能够让重度嗜酸性粒细胞性哮喘患者长期获益

2022-03-15

echonoir (审核中...)

前往app查看评论内容

#嗜酸性粒细胞性哮喘#

Lancet Respirat Med：重度嗜酸性粒细胞性哮喘患者启用贝那利珠单抗后的口服激素减量情况

2022-07-26

echonoir (审核中...)

前往app查看评论内容

#嗜酸性粒细胞性哮喘#

Knopp Biosciences宣布开始II期临床试验评估右旋普拉克索在嗜酸性粒细胞性哮喘中的应用

2020-07-19

echonoir (审核中...)

前往app查看评论内容

#嗜酸性粒细胞性哮喘#

CHMP推荐Nucala（mepolizumab）用于治疗重症嗜酸性粒细胞性哮喘的欧洲患儿

2018-12-04

echonoir (审核中...)

前往app查看评论内容

#嗜酸性粒细胞性哮喘#

Allergy：嗜酸性粒细胞性哮喘患者气道中嗜碱性粒细胞增加并活性！

2017-07-05

科室
- - 订阅+
  - 更多科室
工具
服务